Molecular profiling of liver cancer heterogeneity
Standard
Molecular profiling of liver cancer heterogeneity. / Craig, Amanda J; von Felden, Johann; Villanueva, Augusto.
In: DISCOV MED, Vol. 24, No. 131, 09.2017, p. 117-125.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Molecular profiling of liver cancer heterogeneity
AU - Craig, Amanda J
AU - von Felden, Johann
AU - Villanueva, Augusto
N1 - xxx
PY - 2017/9
Y1 - 2017/9
N2 - Liver cancer has the highest increase in incidence and mortality of all cancers in the United States in recent decades. A major effort has been taken over the last 10 years to understand molecular heterogeneity between tumors of different patients through the development of mutation signatures and molecular classifications. More recently, attention has shifted to understanding intra-tumor heterogeneity (ITH). Several possibilities exist as to the underlying mechanisms that drive ITH in liver cancer, including cancer stem cells (CSCs) and neutral and clonal evolution. Tracking ITH changes in patients over treatment courses will become imperative as precision medicine comes to the forefront of cancer management. Here we review the models of ITH development in liver cancer and the impact ITH assessment can have on clinical management.
AB - Liver cancer has the highest increase in incidence and mortality of all cancers in the United States in recent decades. A major effort has been taken over the last 10 years to understand molecular heterogeneity between tumors of different patients through the development of mutation signatures and molecular classifications. More recently, attention has shifted to understanding intra-tumor heterogeneity (ITH). Several possibilities exist as to the underlying mechanisms that drive ITH in liver cancer, including cancer stem cells (CSCs) and neutral and clonal evolution. Tracking ITH changes in patients over treatment courses will become imperative as precision medicine comes to the forefront of cancer management. Here we review the models of ITH development in liver cancer and the impact ITH assessment can have on clinical management.
KW - Journal Article
M3 - SCORING: Journal article
C2 - 28972880
VL - 24
SP - 117
EP - 125
JO - DISCOV MED
JF - DISCOV MED
SN - 1539-6509
IS - 131
ER -